Brennan David R — SEC insider filings
SEC reporting owner CIK 1609305. 12 insider filings on record with FilingPulse; latest filed 2026-09-11.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2021-05-14 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 10,000 shares, $301,500 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 25,000 shares, $3,100,000 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 25,000 shares @ $124.00 ($3,100,000) in INSMED Inc, filed 2026-09-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| INSMED Inc (INSM) | Director | 10 | 1 leg · 10,000 sh · $301,500 | 1 leg · 25,000 sh · $3,100,000 | 9 |
| ALEXION PHARMACEUTICALS, INC. (ALXN) | Director | 2 | — | — | 6 |
Insider filings — Brennan David R
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-11 | 4 | INSMED Inc (INSM) | Sale (S): 25,000 @ $124 | EDGAR |
| 2026-05-15 | 4 | INSMED Inc (INSM) | Grant/award (A): 3,305 | EDGAR |
| 2026-02-25 | 4 | INSMED Inc (INSM) | Gift (G): 6,000 @ $0 | EDGAR |
| 2025-11-10 | 4 | INSMED Inc (INSM) | Gift (G): 60,000 @ $0 · Gift (G): 60,000 @ $0 | EDGAR |
| 2025-05-19 | 4 | INSMED Inc (INSM) | Grant/award (A): 5,058 | EDGAR |
| 2024-05-15 | 4 | INSMED Inc (INSM) | Grant/award (A): 13,162 | EDGAR |
| 2023-05-15 | 4 | INSMED Inc (INSM) | Grant/award (A): 13,192 | EDGAR |
| 2022-05-13 | 4 | INSMED Inc (INSM) | Grant/award (A): 14,645 | EDGAR |
| 2021-11-03 | 4 | INSMED Inc (INSM) | Purchase (P): 10,000 @ $30.15 | EDGAR |
| 2021-07-23 | 4 | ALEXION PHARMACEUTICALS, INC. (ALXN) | Disposition to issuer (D): 20,873 @ $0 · Disposition to issuer (D): 2,343 (derivative) @ $155.01 · Disposition to issuer (D): 2,706 (derivative) @ $167.97 · Disposition to issuer (D): 2,294 (derivative) @ $138.86 | EDGAR |
| 2021-05-24 | 4 | ALEXION PHARMACEUTICALS, INC. (ALXN) | Grant/award (A): 1,962 @ $0 · Grant/award (A): 1,374 @ $0 | EDGAR |
| 2021-05-14 | 4 | INSMED Inc (INSM) | Grant/award (A): 7,558 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-05-12 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1609305 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs